Eric Lang
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Lang
Pelthos Therapeutics Inc. reported in an 8-K filed July 2, 2025 that Eric Lang was terminated as Chief Medical Officer, effective July 1, 2025. The proxy statement of Pelthos Therapeutics Inc. reports total compensation of $287,502 for Eric Lang in fiscal 2023, including a base salary of $166,767.
“Additionally, on the Closing Date, Dr. Eric Lang’s employment as Chief Medical Officer of the Company was terminated.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Pelthos Therapeutics Inc. (PTHS)
Proxy statement
Start not stated–2025-07-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Pelthos Therapeutics Inc. (PTHS) | Chief Medical Officer | $166,767 | $287,502 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.